Minish Technology lands ~$21M from VIG Partners at ~$105M valuation

What's the deal? South Korean healthtech firm Minish Technology has raised 30 billion won ($21M) from private equity firm VIG PartnersDealroom has a profile for this one. Try Dealroom →, the company announced on May 28. The round values Minish at 150 billion won ($107M), with VIG Partners taking a 20% stake.

Founded in 2021, Minish Technology supplies dental clinics with its proprietary "Minish" solution — a precision restoration treatment that aims to return damaged teeth to their original healthy state. The company provides an end-to-end clinical process spanning prevention, restoration, and anti-ageing, along with materials, equipment, and IT tools.

Why now? Minish has built a global network of 108 provider clinics across Japan (53), South Korea (44), the US (nine), Canada (one), and Singapore (one), with over 220,000 cumulative clinical cases. Revenue hit 14.9 billion won last year, up 44% year on year.

The company also recently acquired MD InnovationDealroom has a profile for this one. Try Dealroom →, which operates Moa Dental, a first-generation dental clinic network brand in South Korea. VIG Partners, which has been active in healthcare and aesthetics investments, said it was drawn to Minish's ultra-precision processing technology and global competitiveness in the growing natural-tooth preservation and anti-ageing market.

What could go wrong? Dental restoration is a crowded space, and scaling a clinic network model across multiple countries brings regulatory, quality-control, and operational complexity. A 20% stake by a private equity firm also raises questions about how much pressure there will be to accelerate growth or pursue an exit.

The signal: VIG Partners deployed this capital through its growth fund — a vehicle that bets on future potential rather than mature cash flows — suggesting the firm views dental healthtech as a distinct, emerging category rather than a conventional healthcare play. With Minish Technology already at breakout stage and 44% year-on-year revenue growth, the investment reflects rising investor conviction that precision dental restoration, sitting at the intersection of health and aesthetics, can scale globally as consumers treat teeth preservation as part of broader anti-ageing routines.

Read more: Wowtale